Covered recipient · General Payments record
CAROL ANN PHILLIPS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care
General Payments · PY2021–2024
$6,644.47
- Reported across 349 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $402.05 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $133.87 | 2 |
| ABBVIE INC. | $66.22 | 3 |
| GlaxoSmithKline, LLC. | $55.61 | 3 |
| BOSTON SCIENTIFIC CORPORATION | $26.31 | 1 |
| Hologic Sales and Service, LLC | $25.62 | 1 |
| DEXCOM, INC. | $24.98 | 1 |
| Daiichi Sankyo Inc. | $21.14 | 1 |
| Lilly USA, LLC | $16.66 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.62 | 1 |
| Nevro Corp. | $15.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.40 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107846409 | CMS |
| ABBVIE INC. | $18.41 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107846411 | CMS |
| ABBVIE INC. | $18.41 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107846413 | CMS |
| Astellas Pharma US Inc | $125.00 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139525012 | CMS |
| Astellas Pharma US Inc | $8.87 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139495272 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $16.62 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086293798 | CMS |
| Boston Scientific Corporation | $26.31 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092444204 | CMS |
| Daiichi Sankyo Inc. | $21.14 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089469305 | CMS |
| Dexcom, Inc. | $24.98 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353248 | CMS |
| GlaxoSmithKline, LLC. | $21.32 | 01/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116256001 | CMS |
| GlaxoSmithKline, LLC. | $16.20 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116483469 | CMS |
| GlaxoSmithKline, LLC. | $18.09 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116224891 | CMS |
| Hologic Sales and Service, LLC | $25.62 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084893489 | CMS |
| Lilly USA, LLC | $16.66 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135577498 | CMS |
| Nevro Corp. | $15.02 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130782434 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.